Your session is about to expire
← Back to Search
PRISM Intervention for Bone Marrow Cancer
Study Summary
This trial is testing whether an intervention called PRISM can help adolescents and young adults who are receiving hematopoietic cell transplantation for hematology malignancy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am unable to take part in interviews due to physical or mental reasons.I cannot read English or Spanish.I am undergoing a stem cell transplant for cancer or a condition that increases cancer risk.I am mentally capable of participating in interviews.I have chosen not to participate in this trial.I cannot speak English.I am within 4 weeks of my stem cell transplant date.I am between 12 and 24 years old.
- Group 1: PRISM (Promoting Resilience in Stress Management)
- Group 2: Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who meets the eligibility criteria for this clinical trial?
"The age range for participants is 12 to 24 years old and must have a diagnosis of bone marrow neoplasms. Currently, the trial has recruited 84 patients with 6 more needed to reach the goal of 90 total participants."
What are PRISM's (Promoting Resilience in Stress Management) official standing with the FDA?
"PRISM (Promoting Resilience in Stress Management) has received a score of 3 from our team at Power. This is based on the fact that it is a Phase 3 trial, indicating that there is both supporting efficacy data and multiple rounds of safety data."
How many people are taking part in this clinical trial?
"This study requires 90 eligible patients to enroll. These participants will be drawn from different hospitals, including Seattle Children's Hospital Cancer and Blood Disorders Center in Seattle, Washington and University of Alabama, Birmingham in Birmingham, Alabama."
Does this clinical trial have an age limit? If so, what is it?
"The age requirement to participate in this clinical trial is 12-24 years old."
At how many different research facilities can patients participate in this trial?
"There are a total of 8 hospitals participating in this study. They are Seattle Children's Hospital Cancer and Blood Disorders Center in Seattle, University of Alabama, Birmingham in Birmingham, Children's Hospital of Los Angeles in Los Angeles, as well as 4 other locations."
Are researchers still looking for participants in this experiment?
"Yes, this clinical trial is currently recruiting patients. The listing on clinicaltrials.gov shows that the study was first posted on April 1st 2019 and last updated on April 18th 2022."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger